Serge Saxonov sold $129k of TXG
Chief Executive Officer at 10x Genomics, Inc.. 9,348 shares at an average of $13.79, traded Aug 22, 2025, filed Aug 26, 2025.
Score components
- +25RoleCEO
- +11Trade size$129k at market
- 0Share of holdings soldSold 1.0% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-25-000321, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 22, 2025 | SOpen-market sale Class A Common Stock | -9,348 | $13.79 | $129k | 945,892 | Aug 26, 2025 |
Related signals
Other insiders at 10x Genomics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $2.0M 25,000 shares | -2% | |
| 32Weak | 10x Genomics, Inc. | Shehnaaz Suliman director | $465k 5,723 shares | -19% | |
| 47Moderate | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $3.0M 46,388 shares | -13% | |
| 48Moderate | 10x Genomics, Inc. | John R Stuelpnagel director | $1.2M 20,000 shares | -6% | |
| 19Weak | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $289k 15,000 shares | -1% | |
| 35Weak | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $367k 16,152 shares | -1% | |
| 26Weak | 10x Genomics, Inc. | Sarah A. Teichmann director | $147k 7,579 shares | -22% | |
| 41Moderate | 10x Genomics, Inc. | Benjamin J. Hindson See Remarks | $145k 7,826 shares | -2% | |
| 48Moderate | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $167k 8,968 shares | -3% | |
| 52Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $179k 9,632 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.